A prospective observational study to evaluate Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Direct acting antivirals in chronic hepatitis C patients.

A prospective observational study to evaluate Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Direct acting antivirals in chronic hepatitis C patients. - Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Direct acting antivirals in chronic hepatitis C patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031086

Enrollment

1000

Registered

2018-02-01

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Chronic hepatitis or cirrhosis patients with HCV 2)Without HCC when participation 3)At least 20 years old when consent is given 4)The patient has been fully informed and has an adequate understanding about the study and has given voluntary written consent before participation

Exclusion criteria

Exclusion criteria: Inappropriate patients who are judged by study-managing doctors

Design outcomes

Primary

Measure	Time frame
frequency of hepatocellular carcinoma after achievement of sustained Viral Response	—

Secondary

Measure	Time frame
1) Frequency of liver tumor 2) Patients' prognosis 3) The factor associated with hepatocellular carcinoma	—

Countries

Japan

Contacts

Public Contactharuki Uojima

Kitasato University School of Medicine Department of Gastroenterology

kiruha@kitasato-u.ac.jp+81-42-778-8111

Outcome results